Home
Random
Nearby
Log in
Settings
Donate
About Wikidata
Disclaimers
Search
(Q34466452)
Watch
English
Nivolumab in NSCLC: latest evidence and clinical potential
scientific article
In more languages
edit
Statements
instance of
scholarly article
1 reference
stated in
Europe PubMed Central
PMCID
4346216
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25755681%20AND%20SRC:MED&resulttype=core&format=json
retrieved
2 March 2020
review article
1 reference
stated in
Europe PubMed Central
title
Nivolumab in NSCLC: latest evidence and clinical potential
(English)
1 reference
stated in
Europe PubMed Central
PMCID
4346216
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25755681%20AND%20SRC:MED&resulttype=core&format=json
retrieved
2 March 2020
author
Raghav Sundar
series ordinal
1
1 reference
stated in
Europe PubMed Central
PMCID
4346216
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25755681%20AND%20SRC:MED&resulttype=core&format=json
retrieved
2 March 2020
Byoung Chul Cho
series ordinal
2
1 reference
stated in
Europe PubMed Central
PMCID
4346216
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25755681%20AND%20SRC:MED&resulttype=core&format=json
retrieved
2 March 2020
author name string
Julie R Brahmer
series ordinal
3
1 reference
stated in
Europe PubMed Central
PMCID
4346216
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25755681%20AND%20SRC:MED&resulttype=core&format=json
retrieved
2 March 2020
Ross A Soo
series ordinal
4
1 reference
stated in
Europe PubMed Central
PMCID
4346216
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25755681%20AND%20SRC:MED&resulttype=core&format=json
retrieved
2 March 2020
publication date
1 March 2015
1 reference
stated in
Europe PubMed Central
PMCID
4346216
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25755681%20AND%20SRC:MED&resulttype=core&format=json
retrieved
2 March 2020
published in
Therapeutic advances in medical oncology
1 reference
stated in
Europe PubMed Central
PMCID
4346216
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25755681%20AND%20SRC:MED&resulttype=core&format=json
retrieved
2 March 2020
volume
7
1 reference
stated in
Europe PubMed Central
PMCID
4346216
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25755681%20AND%20SRC:MED&resulttype=core&format=json
retrieved
2 March 2020
issue
2
1 reference
stated in
Europe PubMed Central
PMCID
4346216
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25755681%20AND%20SRC:MED&resulttype=core&format=json
retrieved
2 March 2020
page(s)
85-96
1 reference
stated in
Europe PubMed Central
PMCID
4346216
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25755681%20AND%20SRC:MED&resulttype=core&format=json
retrieved
2 March 2020
cites work
Association of PD-L1 overexpression with activating EGFR mutations in surgically resected nonsmall-cell lung cancer.
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4346216
retrieved
6 July 2018
Immunotherapy in the treatment of non-small cell lung cancer
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4346216
retrieved
6 July 2018
Immune checkpoint inhibitors: making immunotherapy a reality for the treatment of lung cancer
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4346216
retrieved
6 July 2018
Protein expression of programmed death 1 ligand 1 and ligand 2 independently predict poor prognosis in surgically resected lung adenocarcinoma
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4346216
retrieved
6 July 2018
Immunologic and clinical effects of targeting PD-1 in lung cancer
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4346216
retrieved
6 July 2018
Immune checkpoint blockade: the hope for immunotherapy as a treatment of lung cancer?
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4346216
retrieved
6 July 2018
Programmed cell death-ligand 1 expression in surgically resected stage I pulmonary adenocarcinoma and its correlation with driver mutations and clinical outcomes.
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4346216
retrieved
6 July 2018
Programmed death ligand-1 expression in non-small cell lung cancer
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4346216
retrieved
6 July 2018
Alterations of immune response of Non-Small Cell Lung Cancer with Azacytidine
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4346216
retrieved
6 July 2018
Activation of the PD-1 pathway contributes to immune escape in EGFR-driven lung tumors
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4346216
retrieved
6 July 2018
Relationship between programmed death-ligand 1 and clinicopathological characteristics in non-small cell lung cancer patients
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4346216
retrieved
6 July 2018
Antitumor immune responses induced by ionizing irradiation and further immune stimulation
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4346216
retrieved
6 July 2018
Silica-induced chronic inflammation promotes lung carcinogenesis in the context of an immunosuppressive microenvironment
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4346216
retrieved
6 July 2018
Ipilimumab and its toxicities: a multidisciplinary approach
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4346216
retrieved
6 July 2018
Nivolumab plus ipilimumab in advanced melanoma
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4346216
retrieved
6 July 2018
Safety and Tumor Responses with Lambrolizumab (Anti–PD-1) in Melanoma
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4346216
retrieved
6 July 2018
Vascular normalization as an emerging strategy to enhance cancer immunotherapy
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4346216
retrieved
6 July 2018
Harnessing the immune system for the treatment of non-small-cell lung cancer
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4346216
retrieved
6 July 2018
Combining radiotherapy and cancer immunotherapy: a paradigm shift
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4346216
retrieved
6 July 2018
Immunogenic cell death in cancer therapy
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4346216
retrieved
6 July 2018
Targeting ROS1 with anaplastic lymphoma kinase inhibitors: a promising therapeutic strategy for a newly defined molecular subset of non-small-cell lung cancer.
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4346216
retrieved
6 July 2018
When progressive disease does not mean treatment failure: reconsidering the criteria for progression
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4346216
retrieved
6 July 2018
Safety and Activity of Anti–PD-L1 Antibody in Patients with Advanced Cancer
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4346216
retrieved
6 July 2018
Safety, activity, and immune correlates of anti-PD-1 antibody in cancer
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4346216
retrieved
6 July 2018
Programmed death ligand 2 in cancer-induced immune suppression.
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4346216
retrieved
6 July 2018
Ipilimumab in combination with paclitaxel and carboplatin as first-line treatment in stage IIIB/IV non-small-cell lung cancer: results from a randomized, double-blind, multicenter phase II study.
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4346216
retrieved
6 July 2018
Colocalization of inflammatory response with B7-h1 expression in human melanocytic lesions supports an adaptive resistance mechanism of immune escape
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4346216
retrieved
6 July 2018
The blockade of immune checkpoints in cancer immunotherapy
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4346216
retrieved
6 July 2018
Normalization of the vasculature for treatment of cancer and other diseases
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4346216
retrieved
6 July 2018
Cancer immunoediting: integrating immunity's roles in cancer suppression and promotion
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4346216
retrieved
6 July 2018
Global cancer statistics
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4346216
retrieved
6 July 2018
A novel chemoimmunomodulating property of docetaxel: suppression of myeloid-derived suppressor cells in tumor bearers.
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4346216
retrieved
6 July 2018
Phase I study of single-agent anti-programmed death-1 (MDX-1106) in refractory solid tumors: safety, clinical activity, pharmacodynamics, and immunologic correlates
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4346216
retrieved
6 July 2018
PD-1 and CTLA-4 combination blockade expands infiltrating T cells and reduces regulatory T and myeloid cells within B16 melanoma tumors
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4346216
retrieved
6 July 2018
Pre-treatment with chemotherapy can enhance the antigenicity and immunogenicity of tumours by promoting adaptive immune responses
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4346216
retrieved
6 July 2018
Guidelines for the evaluation of immune therapy activity in solid tumors: immune-related response criteria
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4346216
retrieved
6 July 2018
PD-L1 and PD-L2 modulate airway inflammation and iNKT-cell-dependent airway hyperreactivity in opposing directions
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4346216
retrieved
6 July 2018
Preclinical characterization of 1-7F9, a novel human anti-KIR receptor therapeutic antibody that augments natural killer-mediated killing of tumor cells
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4346216
retrieved
6 July 2018
PD-1 and its ligands in tolerance and immunity
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4346216
retrieved
6 July 2018
Prognostic factors related to clinical response in patients with metastatic melanoma treated by CTL-associated antigen-4 blockade
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4346216
retrieved
6 July 2018
Docetaxel-induced interstitial pneumonitis following non-small-cell lung cancer treatment
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4346216
retrieved
6 July 2018
Expression of LAG-3 by tumor-infiltrating lymphocytes is coincident with the suppression of latent membrane antigen-specific CD8+ T-cell function in Hodgkin lymphoma patients.
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4346216
retrieved
6 July 2018
Gemcitabine selectively eliminates splenic Gr-1+/CD11b+ myeloid suppressor cells in tumor-bearing animals and enhances antitumor immune activity
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4346216
retrieved
6 July 2018
Role of LAG-3 in regulatory T cells.
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4346216
retrieved
6 July 2018
B7-H1 expression on non-small cell lung cancer cells and its relationship with tumor-infiltrating lymphocytes and their PD-1 expression
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4346216
retrieved
6 July 2018
Tumor-associated B7-H1 promotes T-cell apoptosis: a potential mechanism of immune evasion
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4346216
retrieved
6 July 2018
Effectiveness of donor natural killer cell alloreactivity in mismatched hematopoietic transplants
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4346216
retrieved
6 July 2018
B7-DC, a new dendritic cell molecule with potent costimulatory properties for T cells
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4346216
retrieved
6 July 2018
Tumor antigens recognized by T lymphocytes.
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4346216
retrieved
6 July 2018
Interleukin-2 and interferon-alpha in the treatment of patients with advanced non-small-cell lung cancer
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4346216
retrieved
6 July 2018
Long-term results in combined-modality treatment of small cell carcinoma of the lung
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4346216
retrieved
6 July 2018
Tumor B7-H1 and B7-H3 expression in squamous cell carcinoma of the lung.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1177%2F1758834014567470
retrieved
21 January 2018
Molecular pathways: next-generation immunotherapy--inhibiting programmed death-ligand 1 and programmed death-1.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1177%2F1758834014567470
retrieved
21 January 2018
Metronomic cyclophosphamide regimen selectively depletes CD4+CD25+ regulatory T cells and restores T and NK effector functions in end stage cancer patients
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1177%2F1758834014567470
retrieved
21 January 2018
Continuous systemic corticosteroids do not affect the ongoing regression of metastatic melanoma for more than two years following ipilimumab therapy.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1177%2F1758834014567470
retrieved
21 January 2018
ALK gene rearrangements: a new therapeutic target in a molecularly defined subset of non-small cell lung cancer.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1177%2F1758834014567470
retrieved
21 January 2018
Analysis of the response and toxicity to gefitinib of non-small cell lung cancer.
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4346216
retrieved
27 October 2018
Concomitant administration of interleukin-2 plus tumor necrosis factor in advanced non-small cell lung cancer.
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4346216
retrieved
27 October 2018
Clinical significance of programmed death-1 ligand-1 expression in patients with non-small cell lung cancer: a 5-year-follow-up study
1 reference
stated in
PubMed
reference URL
https://pubmed.ncbi.nlm.nih.gov/25755681
retrieved
12 December 2020
based on heuristic
inferred from PubMed ID database lookup
Altered immune function during long-term host-tumor interactions can be modulated to retard autochthonous neoplastic growth
1 reference
stated in
PubMed
reference URL
https://pubmed.ncbi.nlm.nih.gov/25755681
retrieved
12 December 2020
based on heuristic
inferred from PubMed ID database lookup
Differential impairment of regulatory T cells rather than effector T cells by paclitaxel-based chemotherapy
1 reference
stated in
PubMed
reference URL
https://pubmed.ncbi.nlm.nih.gov/25755681
retrieved
12 December 2020
based on heuristic
inferred from PubMed ID database lookup
Identifiers
DOI
10.1177/1758834014567470
1 reference
stated in
Europe PubMed Central
PMCID
4346216
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25755681%20AND%20SRC:MED&resulttype=core&format=json
retrieved
2 March 2020
PMCID
4346216
1 reference
stated in
Europe PubMed Central
PMCID
4346216
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25755681%20AND%20SRC:MED&resulttype=core&format=json
retrieved
2 March 2020
PubMed ID
25755681
1 reference
stated in
Europe PubMed Central
PMCID
4346216
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25755681%20AND%20SRC:MED&resulttype=core&format=json
retrieved
2 March 2020
ResearchGate publication ID
273385046
0 references
Sitelinks
Wikipedia
(0 entries)
edit
Wikibooks
(0 entries)
edit
Wikinews
(0 entries)
edit
Wikiquote
(0 entries)
edit
Wikisource
(0 entries)
edit
Wikiversity
(0 entries)
edit
Wikivoyage
(0 entries)
edit
Wiktionary
(0 entries)
edit
Multilingual sites
(0 entries)
edit